We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Pregnant Women Can Now Test for Amniotic Fluid Leakage at Home

By LabMedica International staff writers
Posted on 29 Aug 2008
A new at-home screening for amniotic fluid leakage during pregnancy could help control a condition that may lead to serious complications such as infections and preterm labor.

The AmniScreen home detection kit is located in a panty liner, and is intended for pregnant women who experience unexplained vaginal wetness. More...
Other potential candidates include high-risk pregnant women, women who have undergone amniocentesis, women who have experienced prior amniotic fluid leakage, and those who are concerned about unexplained wetness. Each AmniScreen test kit contains three panty liners and three drying trays, offering screening in any location. The system works by detecting elevated pH levels, which may indicate amniotic fluid leakage; a pH level greater than or equal to 5.2 produces a blue-green color. Patients are then instructed to report the test results to their healthcare provider for interpretation and medical care. The test should not be used if less than 12 hours have passed since sexual intercourse or vaginal douching, and if there is vaginal bleeding or spotting. The AmniScreen home detection kit is a product of Barr Pharmaceuticals (Montvale, NJ, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"It's important to know when wetness may be caused by amniotic fluid leakage,” said Nancy Jasper, M.D., an assistant clinical professor of obstetrics and gynecology at Columbia University (New York, NY, USA). "This new tool provides pregnant women with an effective way to identify unexplained wetness, with easy-to-read results that should be discussed with their healthcare provider. This important new test is an additional resource which may provide healthcare providers with information to help determine the necessity of a patient hospital or office visit.”

Over 20% of women arriving at the hospital due to wetness they suspect to be caused by amniotic fluid leakage are sent back home after verifying the cause of the wetness is urine (many third trimester pregnancies are accompanied with urine incontinence, specifically when coughing or laughing). On the other hand, many pregnant women do not react to initial amniotic fluid leakage, as they are sure the wetness they sense is from urine incontinence or vaginal discharge, endangering both themselves and the fetus.

Related Links:
Barr Pharmaceuticals


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
Drug Testing Assays
Atellica DT 250 Analyzer
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.